Table II.
Formulation | Mean particle size (nm) | Polydispersity index | Zeta potential (mV) |
---|---|---|---|
SME-1 | 153.5 ± 4.6 | 0.513 ± 0.011 | −9.70 ± 0.83 |
SME-1 with hymecromone | 159.5 ± 3.3 | 0.531 ± 0.022 | −7.50 ± 0.39 |
SME-1 with resveratrol | 152.7 ± 2.8 | 0.472 ± 0.048 | −6.41 ± 0.73 |
SME-2 | 66.7 ± 1.2 | 0.213 ± 0.005 | −7.18 ± 0.71 |
SME-2 with hymecromone | 66.4 ± 1.5 | 0.192 ± 0.014 | −6.09 ± 0.94 |
SME-2 with resveratrol | 61.2 ± 1.6 | 0.183 ± 0.019 | −7.65 ± 0.43 |
SME-3 | 63.5 ± 0.5 | 0.183 ± 0.008 | −8.22 ± 1.54 |
SME-3 with hymecromone | 64.5 ± 1.6 | 0.198 ± 0.016 | −5.88 ± 0.57 |
SME-3 with resveratrol | 68.8 ± 0.2 | 0.203 ± 0.006 | −7.31 ± 0.81 |
SME-4 | 205.8 ± 10.8 | 0.536 ± 0.049 | −9.24 ± 0.61 |
SME-4 with hymecromone | 192.8 ± 1.7 | 0.474 ± 0.033 | −6.54 ± 1.47 |
SME-4 with resveratrol | 192.5 ± 5.0 | 0.476 ± 0.036 | −4.85 ± 0.30 |